Insights provides context and perspective about key pharmacy trends and issues

Cost Management
A Prescription for Better Diabetes Management
Our new RxZERO plan design fordiabetes eliminates member out-of-pocket costs, and enables clients to help membersimprove health outcomes without raising premiums or deductibles More
White Paper
Drug Pipeline
Specialty Pharmacy Pipeline Drugs to Watch – Q1-Q2 2020
Key drugs to watch for in the specialty pharmacy pipeline Q2-Q3 2019 More
Specialty Report
Drug Pipeline
Two New Treatments for Sickle Cell Disease
New drugs likely to offer patients more options. Key consideration for payors will be effectively balancing high — and rising — price tags with appropriate access. More
Feature
Cost Management
White Paper: Gene Therapy
Gene therapies have the potential to relieve tremendous suffering for patients with genetic disorders and together we can find ways to ensure these treatments are accessible for all those... More
White Paper
Care Management
Supporting a New Personal Best in Cancer Care
Transform Oncology Care from CVS Health uses technology and the latest genomic science to solve some of the biggest challenges in oncology management today More
Feature
Drug Pipeline
Pipeline Preview 2020
CVS Health provides an early look at some key Breakthrough Therapies expected to be reviewed by the FDA in 2020 as well as the associated cost implications and expected approval timeframes More
Feature
Care Management
Helping Plan Sponsors Achieve High Quality Ratings
CVS Health can help Medicare plan sponsors achieve high quality ratings by focusing on key measures such as medication adherence and gaps in care. More
Briefing
Specialty
Digital Innovations Help Improve Patient Experience, Outcomes
CareTeams with clinical expertise and digital tools including secure messaging, apps, and wearables help improve outcomes for patients with complex or rare conditions. More
Briefing
Drug Pipeline
New Migraine Drugs Approach Approval
New drugs to treat migraine are approaching approval and could bring relief for many patients, but they portend higher costs. Ongoing monitoring and appropriate utilization strategies can... More
Feature
Drug Pipeline
Specialty Pharmacy Pipeline Drugs to Watch – Q4 2019-Q1 2020
Key drugs to watch for in the specialty pharmacy pipeline Q4 2019-Q1 2020 More
Specialty Report